Abstract
Purpose
To analyse retinal pigment epithelial (RPE) tears following single administration of intravitreal bevacizumab for neovascular age-related macular degeneration (AMD) during early follow-up.
Methods
Interventional, retrospective, non-comparative case series included 397 patients (409 eyes) of the 746 consecutive patients that met the eligibility criteria. Standardized visual acuity testing, fluorescein angiography, and optical coherence tomography were performed. Data collected included status of the fellow eye, previous treatment, subtypes of choroidal neovascularization (CNV), size and composition of the lesion. Multiple linear regression modelling was used to explore the effect of baseline parameters on the RPE tears. Primary end point was occurrence of RPE tears within 6 weeks after therapy.
Results
Fifteen of the 409 eyes (3.6%) developed RPE tear (95% confidence interval: 2.2–6.0, odds ratio: 26.3). The statistical modelling showed significant association between RPE tear and occult without classic CNV/predominantly haemorrhage vspredominantly/minimal classic CNV (P=0.019), as well as medium or large (>4 disc area) vssmall size of the total lesion (P=0.038). Previous treatment and status of the fellow eye did not statistically influence the risk of RPE tears.
Conclusions
An RPE tear can develop in up to 3.6% of eyes with neovascular AMD following single administration of intravitreal bevacizumab in a short-term follow-up. Medium and large lesion size and occult without classic and predominantly haemorrhagic subtype of CNV were important predictive factors. Preoperative assessment of the lesion characteristics may help in identifying the risk of individual patients with neovascular AMD before intravitreal bevacizumab treatment.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Klein R, Klein BEK, Linton KLP . Prevalence of age-related maculopathy. The beaver dam eye study. Ophthalmology 1992; 99: 933–943.
Kvanta A, Algvere PV, Berglin L, Seregard S . Subfoveal fibrovascular membranes in age-related macular degeneration expresses vascular endothelial growth factor. Invest Ophthalmol Vis Sci 1996; 37: 1929–1934.
Kliffen M, Sharma HS, Mooy CM, Kerkvliet S, de Jong PT . Increased expression of angiogenic growth factors in age-related maculopathy. Br J Ophthalmol 1997; 81: 154–162.
Krzystolik MG, Afshari MA, Adamis AP, Gaudreault J, Gragoudas ES, Michaud NA et al. Prevention of experimental choroidal neovascularization with intravitreal antivascular endothelial growth factor antibody fragment. Arch Ophthalmol 2002; 120: 338–346.
Gragoudas ES, Adamis AP, Cunningham Jr ET, Feinsod M, Guyer DR . VEGF Inhibition Study in Ocular Neovascularization Clinical Trial Group. Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 2004; 351: 2805–2816.
Brown DM, Kaiser PK, Michels M, Soubrane G, Heier JS, Kim RY et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 2006; 355: 1432–1444.
Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 2006; 355: 1419–1431.
Rosenfeld PJ, Moshfeghi AA, Puliafito CA . Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration. Ophthalmic Surg Lasers Imaging 2005; 36: 331–335.
Avery RL, Pieramici DJ, Rabena MD, Castellarin AA, Nasir MA, Giust MJ . Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmology 2006; 113: 363–372.
Bashshur ZF, Bazarbachi A, Schakal A, Haddad ZA, El Haibi CP, Noureddin BN . Intravitreal bevacizumab for the management of choroidal neovascularization in age-related macular degeneration. Am J Ophthalmol 2006; 142: 1–9.
Spaide RF, Laud K, Fine HF, Klancnik Jr JM, Meyerle CB, Yannuzzi LA et al. Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration. Retina 2006; 26: 383–390.
Rich RM, Rosenfeld PJ, Puliafito CA, Dubovy SR, Davis JL, Flynn Jr HW et al. Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Retina 2006; 26: 495–511.
Luke M, Warga M, Ziemssen F, Gelisken F, Grisanti S, Schneider T et al. Effects of bevacizumab on retinal function in isolated vertebrate retina. Br J Ophthalmol 2006; 90: 1178–1182, . e-pub 5 June 2006.
Maturi RK, Bleau LA, Wilson DL . Electrophysiologic findings after intravitreal bevacizumab (Avastin) treatment. Retina 2006; 26: 270–274.
Nicolo M, Ghiglione D, Calabria G . Retinal pigment epithelial tear following intravitreal injection of bevacizumab (Avastin). Eur J Ophthalmol 2006; 16: 770–773.
Meyer CM, Mennel S, Schmidt JS, Kroll P . Acute retinal pigment epithelial tear following intravitreal bevacizumab (Avastin) injection for occult choroidal neovascularisation secondary to age related macular degeneration. Br J Ophthalmol 2006; 90: 1207–1208.
Bakri SJ, Patel SP . Retinal pigment epithelial tear following intravitreal bevacizumab. Eye 2007; 21: 424–425.
Gelisken F, Ziemssen F, Voelker M, Bartz-Schmidt KU . Retinal pigment epithelial tear following intravitreal bevacizumab injection for neovascular age-related macular degeneration. Acta Ophthalmol Scand 2006; 84: 833–834.
Spandau UH, Jonas JB . Retinal pigment epithelium tear after intravitreal bevacizumab for exudative age-related macular degeneration. Am J Ophthalmol 2006; 142: 1068–1070.
Shah CP, Hsu J, Garg SJ, Fischer DH, Kaiser R . Retinal pigment epithelial tear after intravitreal bevacizumab injection. Am J Ophthalmol 2006; 142: 1070–1072.
Gamulescu MA, Framme C, Sachs H . RPE-rip after intravitreal bevacizumab (Avastin) treatment for vascularised PED secondary to AMD. Graefes Arch Clin Exp Ophthalmol 2007; 245: 1037–1040, e-pub 21 February 2007.
Chang LK, Sarraf D . Tears of the retinal pigment epithelium. An old problem in a new Era. Retina 2007; 27: 523–534.
Ronan SM, Yoganathan P, Chien FY, Corcostegui IA, Blumenkranz MS, Deramo VA et al. Retinal pigment epithelium tears after intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration. Retina 2007; 27: 535–540.
Chan CK, Meyer CH, Gross JG, Abraham P, Nuthi AS, Kokame GT et al. Retinal pigment epithelial tears after intravitreal bevacizumab injection for neovascular age-related macular degeneration. Retina 2007; 27: 541–551.
Shabeeba R, Hannan SR, Madhusudhana KC, Lotery AJ, Newsom RSB . Retinal pigment epithelial tear following bevacizumab for choroidal neovascular membrane due to age-related macular degeneration. Br J Ophthalmol 2007; 91: 977–978.
Mathews JP, Jalil A, Lavin MJ, Stanga PE . Retinal pigment epithelial tear following intravitreal injection of bevacizumab (avastin): optical coherence tomography and fluorescein angiographic findings. Eye 2007; 21: 1004–1005.
Macular Photocoagulation Study Group. Subfoveal neovascular lesions in age-related macular degeneration: guidelines for evaluation and treatment in the Macular Photocoagulation Study. Arch Ophthalmol 1991; 109: 1242–1257.
Verteporfin Roundtable Participants. Guidelines for using verteporfin (Visudyne) in photodynamic therapy for choroidal neovascularization due to age-related macular degeneration and other causes: update. Retina 2005; 25: 119–134.
Hoskin A, Bird AC, Sehmi K . Tears of detached retinal pigment epithelium. Br J Ophthalmol 1981; 65: 859–865.
Gass JD . Retinal pigment epithelial rip during krypton red laser photocoagulation. Am J Ophthalmol 1984; 98: 700–706.
Gelisken F, Inhoffen W, Partsch M, Schneider U, Kreissig I . Retinal pigment epithelial tear after photodynamic therapy for choroidal neovascularization. Am J Ophthalmol 2001; 131: 518–520.
Goldstein M, Heilweil G, Barak A, Loewenstein A . Retinal pigment epithelial tear following photodynamic therapy for choroidal neovascularization secondary to AMD. Eye 2005; 19: 1315–1324.
Dhalla MS, Blinder KJ, Tewari A, Hariprasad SM, Apte RS . Retinal pigment epithelial tear following intravitreal pegaptanib sodium. Am J Ophthalmol 2006; 141: 752–754.
Amselem L, Pulido JS, Diaz-Llopis M, Cervera E, Montero J . Retinal pigment epithelial tear following ranibizumab use. Eye 2007; 21(6): 846–847, e-pub ahead of print 26 January.
Casswell AG, Kohen D, Bird AC . Retinal pigment epithelial detachments in the elderly: classification and outcome. Br J Ophthalmol 1985; 69: 397–403.
Pauleikhoff D, Loeffert D, Spital G, Radermacher M, Dohrmann J, Lommatzsch A et al. Pigment epithelial detachment in elderly. Clinical differentiation, natural course and pathogenetic implications. Graefes Arch Clin Exp Ophthalmol 2002; 533–538.
Chuang EL, Bird AC . Bilaterality of tears of the retinal pigment epithelium. Br J Ophthalmol 1988; 72: 918–920.
Reynders S, Lafaut BA, Aisenbrey S, Broecke CV, Lucke K, Walter P et al. Clinicopathologic correlation in hemorrhagic age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 2002; 240: 279–285.
Scupola A, Coscas G, Soubrane G, Balestrazzi E . Natural history of macular subretinal hemorrhage in age-related macular degeneration. Ophthalmologica 1999; 213: 97–102.
Author information
Authors and Affiliations
Corresponding author
Additional information
Financial interest:None
This article was presented in part at the combined Meeting of Club Gonin and The Retina Society, October 2006, Cape Town.
Supplementary Information accompanies the paper on Eye website (http://www.nature.com/eye).
Supplementary information
Rights and permissions
About this article
Cite this article
Gelisken, F., Ziemssen, F., Voelker, M. et al. Retinal pigment epithelial tears after single administration of intravitreal bevacizumab for neovascular age-related macular degeneration. Eye 23, 694–702 (2009). https://doi.org/10.1038/sj.eye.6703098
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.eye.6703098
Keywords
This article is cited by
-
Impact of Agarose Hydrogels as Cell Vehicles for Neo Retinal Pigment Epithelium Formation: In Vitro Study
Macromolecular Research (2022)
-
Pigment epithelial tears after ranibizumab injection in polypoidal choroidal vasculopathy and typical age-related macular degeneration
Graefe's Archive for Clinical and Experimental Ophthalmology (2015)
-
Seröse vaskularisierte Pigmentepithelabhebungen bei exsudativer altersbedingter Makuladegeneration
Der Ophthalmologe (2015)
-
Retinal Pigment Epithelium Tear
Current Ophthalmology Reports (2015)
-
Pigmentepithelabhebung bei exsudativer Makuladegeneration
Der Ophthalmologe (2010)
